Pan, Chong-Xian <br/><br/>
A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.  [electronic resource] 

 -  Oncology  2005 
 - 63-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000087302  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Celecoxib<br/>Colorectal Neoplasms--drug therapy<br/>Cyclooxygenase Inhibitors--therapeutic use<br/>Diarrhea--chemically induced<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Glutamine--therapeutic use<br/>Humans<br/>Irinotecan<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Pyrazoles--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Treatment Outcome